Companion Diagnostics Market 2030: A New Era in Oncology
The global companion diagnostics market was valued at USD 9,058.1 million in 2024 and is expected to reach USD 15,977.6 million by 2030, growing at a CAGR of 10.5% from 2025 to 2030. Companion diagnostics play a vital role in customizing treatments by identifying biomarkers that predict how patients will respond to specific therapies. The increasing prevalence of diseases such as cancer, cardiovascular disorders, and autoimmune conditions has intensified the demand for targeted therapies, where companion diagnostics are essential for selecting the most effective treatments. This personalized approach reduces adverse side effects and improves treatment success rates, thereby enhancing patient outcomes. The transition from uniform treatment methods to personalized medicine stands as a major growth driver. Additionally, pharmaceutical companies are integrating companion diagnostics into their drug development processes to increase the chances of success for new therapeutics, further pro...